N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

被引：0
|
作者：
Oliver Wirths
Susanne Walter
Inga Kraus
Hans W. Klafki
Martina Stazi
Timo J. Oberstein
Jorge Ghiso
Jens Wiltfang
Thomas A. Bayer
Sascha Weggen
机构：
[1] University Medical Center (UMG),Division of Molecular Psychiatry
[2] Georg-August-University,Department of Psychiatry and Psychotherapy
[3] University Medical Center (UMG),Department of Neuropathology
[4] Georg-August-University,Department of Psychiatry and Psychotherapy
[5] Heinrich-Heine-University,Department of Pathology
[6] Friedrich-Alexander-University of Erlangen-Nuremberg,Departments of Psychiatry
[7] New York University School of Medicine,Institute for Research in Biomedicine (iBiMED), Medical Sciences Department
[8] New York University School of Medicine,undefined
[9] German Center for Neurodegenerative Diseases (DZNE),undefined
[10] University of Aveiro,undefined
来源：
Alzheimer's Research & Therapy | / 9卷
关键词：
Alzheimer’s disease; N-truncated Amyloid-β; Immunohistochemistry; Mouse model; Postmortem; 5XFAD; APP/PS1KI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Transgenic Mouse Models of Alzheimer's Disease
    Elder, Gregory A.
    Sosa, Miguel A. Gama
    De Gasperi, Rita
    MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (01): : 69 - 81
  • [12] Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease
    Bayer, Thomas A.
    Wirths, Oliver
    ACTA NEUROPATHOLOGICA, 2014, 127 (06) : 787 - 801
  • [13] Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models
    Wirths, O.
    Bayer, T. A.
    GENES BRAIN AND BEHAVIOR, 2008, 7 : 1 - 5
  • [14] Synergistic Effect on Neurodegeneration by N-Truncated Aβ4-42 and Pyroglutamate Aβ3-42 in a Mouse Model of Alzheimer's Disease
    Lopez-Noguerola, Jose S.
    Giessen, Nicolai M. E.
    Ueberueck, Maximilian
    Meissner, Julius N.
    Pelgrim, Charlotte E.
    Adams, Johnathan
    Wirths, Oliver
    Bouter, Yvonne
    Bayer, Thomas A.
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [15] Can mouse models mimic sporadic Alzheimer's disease?
    Bettina M.Foidl
    Christian Humpel
    Neural Regeneration Research, 2020, 15 (03) : 401 - 406
  • [16] Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
    Thomas Wisniewski
    Allal Boutajangout
    Brain Structure and Function, 2010, 214 : 201 - 218
  • [17] Transgenic mouse models of Alzheimer's disease: phenotype and application
    Higgins, GA
    Jacobsen, H
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 (5-6): : 419 - 438
  • [18] Alzheimer's disease: Transgenic mouse models and drug assessment
    Yu, P
    Oberto, G
    PHARMACOLOGICAL RESEARCH, 2000, 42 (02) : 107 - 114
  • [19] Retinal Changes in Transgenic Mouse Models of Alzheimer's Disease
    Guo, Li
    Ravindran, Nivedita
    Shamsher, Ehtesham
    Hill, Daniel
    Cordeiro, M. Francesca
    CURRENT ALZHEIMER RESEARCH, 2021, 18 (02) : 89 - 102
  • [20] Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models
    Wisniewski, Thomas
    Boutajangout, Allal
    BRAIN STRUCTURE & FUNCTION, 2010, 214 (2-3) : 201 - 218
12345